Real-time enrollment status for this cannabinoid hyperemesis syndrome clinical trial
Current Status
Recruiting
Checked: July 22, 2026 at 11:33 PM UTC
| NCT Number | NCT07246187 |
| Recruiting Status | Recruiting |
| Condition | Cannabinoid Hyperemesis Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 114 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Mercy Bon Secours Saint Vincent Medical Center |
| Last Updated on CT.gov | November 24, 2025 (Nov 24, 2025) |
As of July 22, 2026: Clinical trial NCT07246187 is currently recruiting participants. This phase3 study for cannabinoid hyperemesis syndrome is actively seeking new participants at 1 location across the United States. The study is sponsored by Mercy Bon Secours Saint Vincent Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07246187 is actively recruiting participants as of July 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07246187 was last updated Nov 24, 2025 (November 24, 2025). HelloStudys verifies this status automatically.